The "master transcription factor" FOXP3 regulates the differentiation, homeostasis, and suppressor function of CD4 + regulatory T (Treg) cells, which are critical in maintaining immune tolerance. Epigenetic regulation of FOXP3 expression has been demonstrated to be important to Treg cell development, but the induction of human Treg cells through epigenetic modification has not been clearly described. We report that the combination of the DNA methyltransferase inhibitor 5-azacytidine (5-Aza) and suboptimal T cell receptor (TCR) stimulation promoted CD4 
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The subset of CD4 + T lymphocytes called regulatory T (Treg) cells have been demonstrated to prevent autoimmune disease and transplant rejection in human and experimental animal models (1, 2) . Over the last decade, intense study of Treg cell gene expression, surface markers, and suppressor function has revealed two Treg populations. Natural Treg (nTreg) cells are CD4
+ T cells with strong T cell receptor (TCR) signaling that survive negative selection, develop, and mature in the thymus. Adaptive Treg cells are induced in the periphery following specific tolerogenic stimulation (3) . The forkhead winged-helix transcription factor FOXP3 has been shown to be critical for Treg cell differentiation and function. Ectopic expression of FOXP3 confers suppressive function and activates Treg cell signature genes, such as Il2ra (CD25), Ctla4 (CTLA-4), and Tnfrsf18 (GITR), in peripheral CD4 + CD25 − T cells (4, 5) . Activation of human CD4 + CD25 − T cells through TCR stimulation results in transient, low level expression of FOXP3 without conferring suppressive activity (6, 7) , indicating that FOXP3 must be constitutively expressed to maintain Treg cell function.
Various protocols have been developed to induce Treg cells from naive CD4 + CD25 − T cells. These include using a variety of APCs such as tolerogenic agent-treated DC (8) (9) (10) and plasmacytoid DC (11) , cytokines such as transforming growth factor (TGF)-β (12) and IL-35 (13) , and suboptimal antigenic activation (14) . These efforts have produced FOXP3 expression and suppressor function of variable strength and stability. It has been reported that DNA demethylation in the foxp3 gene controls FOXP3 expression (15, 16) and the foxp3 methylation state discriminates bona fide Treg cells from activated FOXP3
+

CD4
+ T cells (17) . Furthermore, several factors critical for Treg cell development, such as IL-2 receptor alpha chain (also called CD25) (18) and galectin-1 (19) , are also regulated by the methylation of CpG islands in the respective promoter regions. These studies indicate that the induction of Treg cells in vitro may be enhanced by modifying the ability of CD4 + T cells to demethylate DNA.
The typical inhibitor of DNA methyltransferase, 5-azacytidine (5-Aza), is a derivative of the nucleoside cytidine and approved by the FDA to treat myelodisplastic syndrome (MDS) (20) . Some studies demonstrated that 5-Aza is capable of inducing strong expression of FOXP3 in mouse CD4 + CD25 − T cells (15, 16, 21, 22) . Similar results were also observed in human CD4 + CD25 − T cells (16, 23 
CD25
h T cells, were enhanced by 5-Aza treatment, which triggered partial demethylation of Treg-specific demethylated region (TSDR) within the FOXP3 gene. The 5-Aza-treated CD4
+
CD25
h T cells were hyporesponsive to TCR engagement and did not produce IL-2 after restimulation. Moreover, 5-Azatreated induced Treg cells could be expanded with exogenous IL-2 alone and retained FOXP3 expression and their suppressive activity after expansion.
MaTerials anD MeThODs
Blood samples
Adult peripheral blood obtained from healthy volunteers was acquired in accordance with the approval of Medical Ethics and Human Clinical Trial Committee of the Chung Gung Memorial Hospital. All subjects who were participated in this study gave written informed consent in accordance with the Declaration of Helsinki.
isolation of cD4
Peripheral blood mononuclear cells (PBMCs) were isolated by density gradient centrifugation over Ficoll-Paque (GE Healthcare) at 3000 rpm for 16 min. CD4 + CD25 − T cells were separated using a magnetic cell sorting (MACS) system (Miltenyi-Biotec). Briefly, CD4
+ T cells were isolated from PBMCs by negative selection using an LD column. Purified CD4 + T cells were subsequently incubated with anti-CD25 antibody-coated beads, and CD4 + CD25 − and CD4 + CD25 + T cell fractions were separated by an MS column. The purity of isolated population was over 95% as determined by FACS analysis.
cell culture
CD4
+ CD25 − T cells isolated from PBMC of healthy donors were cultured at 1 × 10 6 cells/ml in RPMI1640 supplemented with 2 mM l-glutamine, 1% pyruvate, 100 U/ml penicillin, 100 μg/ml streptomycin (Thermo Fisher Scientific), 50 μM 2-mercaptoethanol (Sigma-Aldrich), and 10% heat-inactivated fetal bovine serum (FBS, GE Healthcare). The cells were activated by incubation with anti-CD2, anti-CD3, and anti-CD28 antibodies-coated beads (Miltenyi-Biotec) at a beads-to-cells ratio of 1:8 in the presence or absence of 5 μM 5-Aza (Sigma-Aldrich) for 4 days. For the examination of IL-2 effects on FOXP3 expression, neutralizing anti-human IL-2 and the isotype control antibodies (40 μg/ml) (Biolegend) were added to the cultures with 5-Aza treatment, respectively, at the beginning of the culture. Furthermore, recombinant human IL-2 (100 U/ml) (PeproTech) was also added to 5-Aza-untreated cultures. At the end of culture, cells were harvested for cellular characterization, and supernatants were collected for cytokine measurement.
Flow cytometric analysis
Harvested T cells were washed with 1× PBS (Sigma-Aldrich). The cell suspensions were then stained for 30 min at 4°C with the following mixtures of monoclonal antibodies (mAbs) against human antigens: (i) anti-CD4-FITC (clone PRA-T4), anti-CD25-APC (clone BC96), and anti-GITR-PE (clone 621), anti-CTLA-4-PE (clone BNI3), anti-HLA-DR-PE (clone L243), anti-LAP-PE (clone 27232), or anti-CD127-PE (clone hIL-7R-M21) and (ii) anti-CD4-PE (clone PRA-T4), anti-CD25-APC (Clone BC96), and anti-CD62L-FITC (clone DREG-56) or anti-CD134-FITC (clone ACT35). After staining, cells were washed and resuspended in 1× PBS. For intracellular FOXP3, perforin and granzyme B staining, cells were stained with anti-CD4-FITC and anti-CD25-APC or anti-CD4-FITC and anti-CD25-PE (clone BC96) and were next processed with FOXP3/Transcription Factor Staining Buffer Set (eBioscience) according to the manufacturer's instructions. Anti-FOXP3-PE (clone PCH101) or anti-perforin-PE (clone δG9) was added into cells stained with anti-CD4-FITC and anti-CD25-APC, and anti-granzyme B-Alexa Fluor 647 (clone GB11) was added into cells stained with anti-CD4-FITC and anti-CD25-PE. Incubation was performed at 4°C for 30 min. For intracellular IL-2 staining, cells were restimulated with 50 ng/ml PMA and 0.5 μg/ml ionomycin (Sigma-Aldrich) in the presence of BD GolgiPlug (BD Biosciences) for 4 h before staining. After restimulation, cells were stained with anti-CD4-FITC and anti-CD25-PE followed by fixation and permeabilization as previous description. The cells were then incubated with anti-IL-2-APC (clone MQ1-17H12) at 4°C for 30 min. Data were acquired on a FACSCalibur flow cytometer (BD Biosciences) and analyzed using the Cell-Quest software (BD Biosciences). Anti-CD4, anti-CD25, anti-CD62L, anti-GITR, anti-HLA-DR, and anti-IL-2 were purchased from Biolegend; anti-CD127, anti-CD134, anti-perforin, and anti-granzyme B were from BD Pharmingen; anti-CTLA-4 was from Serotec; and anti-FOXP3 was from eBioscience.
cytokine Measurement
The concentration of IL-2, IL-10, interferon (IFN)-γ, and TGF-β in the culture supernatants were evaluated with ELISA kit (R&D Systems) according to the manufacturer's instructions. For transwell assay, the responder cells were labeled with CFSE (5 μM, Thermo Fisher Scientific) for 10 min at 37°C. CFSElabeled responder cells were stimulated with anti-CD2, anti-CD3, and anti-CD28 antibodies-coated beads at a 1:2 beads-to-cells ratio in 24-well plates (2.5 × 10 5 cells/well). The suppressor cells were added to the culture at a 1:1 R:S ratio but separated from the responder cells by a Millicell insert (Millipore) for 3 days. The CFSE dilution was analyzed using a FACSCalibur cytometer.
In Vitro suppression assay
rna isolation and mrna expression analysis
Total RNA was isolated from CD4 + CD25 − and CD4
+ CD25 h cells that were sorted from 5-Aza-treated or 5-Aza-untreated T cells using a combination of TRIzol reagent (Thermo Fisher Scientific) and chloroform to purify the RNA. The quantity of RNA was determined by Nanodrop ND-1000 (Thermo Fisher Scientific). For cDNA synthesis, 1 μg of RNA was mixed with 10× reaction buffer and DNase I (Thermo Fisher Scientific) and incubated at 37°C for 30 min. DNase I was inactivated by incubation with 50-mM EDTA at 65°C for 10 min. The DNase I-treated RNA was then mixed with random hexamers (Thermo Fisher Scientific) and incubated at 70°C for 10 min. cDNA was synthesized with M-MLV Reverse Transcriptase (Thermo Fisher Scientific) at 37°C for an hour, and the reaction was inactivated at 70°C for 10 min. Real-time PCR was performed using SYBR Green PCR Master Mix (Thermo Fisher Scientific). RNA expression was measured using the following primers:
FOXP3 forward, 5′-CCCCTGGAGAGCCCAGCCAT-3′ FOXP3 reverse, 5′-GGCACAGCCGAAAGGGTGCT-3′ GAPDH forward, 5′-GAAGGTGAAGGTCGGAGTC-3′ GAPDH reverse, 5′-GAAGATGGTGATGGGATTTC-3′.
Dna extraction and Dna Methylation analysis
DNA was extracted from CD4
+ CD25 h cells that were sorted from suboptimally activated T cells treated with or without 5-Aza, and CD4 
cell lysate Preparation and immunoblotting
Naive CD4 + CD25 − T cells (1 × 10 6 cells/ml) with suboptimal TCR stimulation were treated with or without 5-Aza in the 24-well plate. Cells were harvested 4 days later and incubated with lysis buffer containing 0.1M NaCl, 20 mM Tris-HCl, 5 mM MgCl2, 0.5% NP-40, and protease inhibitor (Sigma-Aldrich) on ice for 30 min. Cell lysates were collected after centrifugation performed at 16,000 × g for 30 min at 4°C. The lysates were separated by 8% SDS-PAGE and transferred to nitrocellulose membranes (GE Healthcare). Antibodies against DNMT1 (Santa Cruz) and β-actin (Sigma-Aldrich) were used to visualize the corresponding proteins.
statistical analysis
Statistical analyses were performed using Prism software (GraphPad). Mann-Whitney U test was used to compare all data. These data are presented as means ± SD. P values <0.05 were considered statistically significant. dim cells were excluded. One representative sample of nine experiments is shown. The results are shown as mean ± SD (*P < 0.05; **P < 0.01; ***P < 0.001). 
CD25
− T cells isolated from PBMCs were stimulated with anti-CD2/CD3/CD28-coated beads at different bead-to-cell ratios in the presence or absence of 5-Aza for 4 days. Under suboptimal stimulation, 5-Aza-treated T cells expressed CD25 at much higher levels compared to -untreated ones ( Figure S1A in Supplementary Material). To confirm that CD25 expression correlated to Treg cells, we measured the levels of the Treg master transcription factor FOXP3. FOXP3 expression was low in CD25 dim cells and barely detectable in CD25 − cells with or without 5-Aza treatment (data not shown). The clone of the antibody we used to detect FOXP3 was PCH101, which has been reported to have high level of non-specific staining (24) . Thus, we gated 
5-aza-Treated cD4
+ cD25 h T cells suppressed allogeneic cD4 + T cell activation It has been demonstrated that Treg cells exert their regulatory function through cell-to-cell contact in vitro. We next used transwell assays to verify the inhibitory mechanism of 5-Aza-treated CD4
+ CD25 h T cell. CFSE-labeled responder cells expanded largely upon optimal TCR stimulation ( Figure 2C) . As expected, proliferation was dramatically hindered when responder cells were cocultured with 5-Aza-treated CD4 + CD25 h Treg cells. However, the suppression was abolished when the two cell populations were separated by a semi-permeable insert. Similarly, 5-Aza-treated CD4 + CD25 h Treg cells were able to suppress responder cell production of IL-2, although IL-2 production did not recover completely when cell-to-cell contact was prevented ( Figure 2D ). After stimulation, 5-Aza-treated CD4 + CD25 h T cells, which we had previously demonstrated their hyporesponsive characteristic, did not produce IL-2 ( Figure 2D ). Further examination of the molecules that have been proposed to determine Treg cell functionality revealed that perforin and granzyme B were dramatically upregulated in 5-Aza-treated CD4 + CD25 h Treg cells ( Figure 2E ). These data demonstrated the potential application of 5 
T cells
The TSDR in the foxp3 loci has been proposed to be hypomethylated in Treg cells. Demethylation within TSDR is not seen in activated T cells that transiently express FOXP3 (17, 25) . To elucidate the effect of the methyltransferase inhibitor 5-Aza on Treg induction, we examined the foxp3 methylation pattern in T cells. Consistent with previous reports, we found that the TSDR was hypomethylated in nTreg but hypermethylated in naive T cells ( Figure 3A) . Partial demethylation was observed in 5-Aza-treated CD4 + CD25 h cells, but the hypermethylated pattern was not changed in 5-Aza-untreated CD4 + CD25 h cells. To investigate the effect of demethylation by 5-Aza treatment on gene expression, we analyzed total RNA extracted from 5-Aza-treated and -untreated CD4 + CD25 h T cells. As shown in Figure 3B , foxp3 was upregulated in 5-Aza-treated CD4 + CD25 h T cells compared to the 5-Aza-untreated cells. The expression of dnmt1, dnmt3a, and dnmt3b was also examined. They were expressed comparably between the 5-Aza-treated and -untreated cell populations (data not shown). Although the expression of dnmt family genes was not affected, we found that protein amounts of DNMT1 were downregulated in 5-Aza-treated T cells, but not in their counterparts ( Figure 3C ). These data showed that decrease of DNA methylation in naive T cells through reduction of DNMT1 by 5-Aza increased FOXP3 expression and potentiated their regulatory function.
il-2 Was indispensible to the enhanced FOXP3 expression in 5-aza-Treated cD4
+ cD25 h T cells
Cytokines, such as IL-2 or TGF-β, have important effects on the development and function of Treg cells. We hence studied the cytokine production of suboptimally activated T cells under the influence of 5-Aza. As shown in Figure 4A , the level of IL-2 produced by 5-Aza-treated, suboptimally activated T cells was higher, but the level of IFN-γ was similar, compared to -untreated T cells. Next, we analyzed the levels of the inhibitory cytokines IL-10 and TGF-β. The production of IL-10 was reduced when T cells were treated with 5-Aza, whereas that of TGF-β was comparable ( Figure 4A ). Since IL-2 is critical to + CD25 h T cells, which altogether suggested that IL-2 production was indispensable to the enhanced Treg induction effect of DNA demethylation. To further investigate the origin of IL-2 secretion, cultured cells were restimulated with PMA and ionomycin in the presence of GolgiStop. After restimulation, IL-2 was barely detectable in CD25 h T cells irrespective of 5-Aza treatment. Surprisingly, the major population producing IL-2 was CD25 dim T cells, which actually produced more IL-2 when they had been treated with 5-Aza ( Figure 4C) . These results demonstrated that 5-Aza treatment enhanced the induction of Treg cells from CD4 + CD25 − T cells directly by modifying FOXP3 protein expression in CD25 h T cells as well as indirectly by increasing IL-2 production in CD25 dim cells. 
5-aza-Treated cD4
DiscUssiOn
Ex vivo generation of Treg cells promises to revolutionize therapy for promoting tolerance post-transplantation and modulating the severity of autoimmunity and allergy. Heretofore, attempts to induce Treg cells from human CD4 + T cells have yet to produce stable FOXP3 + T cells capable of maintaining suppression. Activation thresholds have been proposed to be responsible for the peripheral tolerance (26) , and suboptimal T-cell activation was found to promote induction of Treg cells in an autonomous TGF-β-dependent manner in murine systems (14, 27) . In this study, we have demonstrated that DNA demethylation by 5-Aza can promote Treg cell induction by suboptimal TCR stimulation of human CD4 + CD25 − T cells through increasing IL-2 production in CD25 dim and CD25 − cells. The increased IL-2 synergistically enhanced FOXP3 expression in CD25 h cells. Induced FOXP3 + T cells that had been treated with 5-Aza showed all the hallmarks of Treg cells, including expression of CTLA-4 and GITR, downregulated expression of CD127, production of TGF-β, and the capability of suppressing responder T-cells in a contact-dependent manner. Importantly, 5-Aza-treated Treg cells could be expanded ex vivo with IL-2 alone and maintained FOXP3 expression and their suppressive function after expansion.
Using DNA methyltransferase inhibitor to induce FOXP3 expression has been extensively studied in mice (16, 22, 28) . However, induction of FOXP3 expression with epigenetic modification in human is still controversial. Lal and colleagues reported + CD25 − T cells by the combination of 5-Aza-2′-deoxycytidine (5-Aza-dC) and TGF-β in the presence of exogenous IL-2, and they performed steady suppressive activity (16) . Nevertheless, the resulting cells' phenotype and regulatory function were not fully characterized. Furthermore, TGF-β-induced FOXP3 + cells in human system are still controversial (24, 29) . We here show that the combination of suboptimal TCR stimulation and 5-Aza treatment induced a population of human CD4 + T cells that expressed higher level of CD25 and FOXP3 as well as CTLA-4 and GITR when compared to the 5-Aza-untreated counterparts, and the amounts of TGF-β in the supernatants of 5-Aza-treated and -untreated groups were comparable, which might suggest the enhanced expression of CD25, FOXP3, CTLA-4, and GITR was TGF-β independent. Despite no significant difference compared to non-5-Aza-treated cells, downregulated expression of CD127 in 5-Aza-treated CD4 + CD25 h T cells corresponded to the level in nTreg cells. Moreover, sorted 5-Aza-treated CD4 +
CD25
h T cells not only were hyporesponsive to TCR engagement but also demonstrated potent suppressive activity in a contact-dependent manner, which are the two characteristics of nTreg cells observed in vitro (30) . It is worth mentioning that the strength of suppression mediated by 5-Aza-treated CD4 +
h T cells in vitro is comparable to that of nTreg cells. Still, before 5-Aza-treated CD4 + CD25 h T cells can be called "true" induced Treg cells, their transcription profile has to be compared to that of nTreg cells, and their suppressor function needs to be tested in vivo in an immunological setting such as the xenogeneic graft-versus-host disease (GvHD) model in NOD-scid-γc − (NSG) mouse (31) . Demethylation of the CpG island in the Treg-specific demethylation region (TSDR) has been reported to promote stable and constitutive FOXP3 expression in nTreg cells (32, 33) . However, whether the TSDR is demethylated in the in vivo generated peripheral Treg (21, 34) A previous study reported by Kehrmann et al. indicated that 5-Aza-dC reduced methylation within TSDR and increased FOXP3 expression in the 5-Aza-dC-treated CD4 + CD25 − cells, as well as the mRNA expression of T helper (Th)1-, Th2-, and Th17-related transcription factors (40) . They found that the 5-Aza-dC-treated cells did not suppress the proliferation of responder cells, suggesting the loss of suppressive ability of 5-Aza-dC-treated cells despite the increased FOXP3 expression. In our opinion, the culture of CD4 + CD25 − T cells results in a heterogeneous cell population with varying CD25 expression. Isolation of CD25 h FOXP3 + cells is necessary to study the role of 5-Aza-dC treatment on Treg suppressive function. Furthermore, optimal TCR stimulation may trigger the differentiation of naive T cells into effector Th cell populations (41) . Contrary to their study, we have demonstrated that sorted 5-Aza-treated CD4 + CD25 h T cells expressed important Treg cell markers, were not responsive to TCR stimulation, and showed potent suppressive function. To address the concern that adult peripheral blood contains a large fraction of effector/memory CD4 + T cells, which are CD45RA − CD45RO + , the addition of CD45RA as a marker to select for pure naive CD4
+ T cells could significantly raise the efficiency of Treg cell induction.
IL-2 signaling is critically required for the development and homeostasis of Treg cells for dominant immunotolerance in vivo (42) . Previous studies also emphasized the important role of IL-2 in the conversion of Treg cells from naive cells by TGF-β (37, 43) . Our results demonstrated that IL-2 was increased in the 5-Azaconditioned culture. The IL-2 produced mainly by the CD25 The authors would like to thank all the healthy volunteers for participating in this study.
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